Capital Planning Advisors LLC reduced its stake in Oracle Co. (NYSE:ORCL - Free Report) by 8.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 22,047 shares of the enterprise software provider's stock after selling 2,028 shares during the quarter. Capital Planning Advisors LLC's holdings in Oracle were worth $3,674,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds have also recently made changes to their positions in ORCL. State Street Corp raised its holdings in Oracle by 2.7% in the 3rd quarter. State Street Corp now owns 70,441,556 shares of the enterprise software provider's stock worth $12,003,241,000 after purchasing an additional 1,847,561 shares during the period. Geode Capital Management LLC raised its holdings in Oracle by 2.6% in the 3rd quarter. Geode Capital Management LLC now owns 35,194,683 shares of the enterprise software provider's stock worth $5,977,015,000 after purchasing an additional 885,041 shares during the period. Franklin Resources Inc. raised its holdings in Oracle by 11.6% in the 3rd quarter. Franklin Resources Inc. now owns 18,480,384 shares of the enterprise software provider's stock worth $3,370,640,000 after purchasing an additional 1,917,416 shares during the period. Fisher Asset Management LLC raised its holdings in Oracle by 1.8% in the 3rd quarter. Fisher Asset Management LLC now owns 17,898,029 shares of the enterprise software provider's stock worth $3,049,824,000 after purchasing an additional 310,709 shares during the period. Finally, Janus Henderson Group PLC raised its holdings in Oracle by 0.4% in the 3rd quarter. Janus Henderson Group PLC now owns 14,608,951 shares of the enterprise software provider's stock worth $2,489,345,000 after purchasing an additional 54,868 shares during the period. 42.44% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
A number of brokerages have issued reports on ORCL. Royal Bank of Canada reiterated a "sector perform" rating and issued a $165.00 price target on shares of Oracle in a research note on Thursday, December 5th. Morgan Stanley increased their price target on Oracle from $145.00 to $175.00 and gave the stock an "equal weight" rating in a research note on Tuesday, December 10th. BMO Capital Markets raised their price objective on Oracle from $173.00 to $205.00 and gave the company a "market perform" rating in a research report on Tuesday, December 10th. Cantor Fitzgerald started coverage on Oracle in a research report on Friday, January 17th. They set an "overweight" rating and a $214.00 price objective for the company. Finally, StockNews.com raised shares of Oracle from a "hold" rating to a "buy" rating in a research note on Thursday, January 16th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating, eighteen have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Oracle currently has an average rating of "Moderate Buy" and an average price target of $182.73.
Read Our Latest Report on ORCL
Oracle Price Performance
Shares of ORCL stock traded up $1.86 on Thursday, reaching $186.08. 17,288,570 shares of the company were exchanged, compared to its average volume of 13,592,791. The company has a market cap of $520.44 billion, a price-to-earnings ratio of 45.50, a P/E/G ratio of 3.39 and a beta of 1.06. The business has a 50-day moving average price of $174.43 and a 200 day moving average price of $162.05. The company has a debt-to-equity ratio of 5.65, a quick ratio of 0.81 and a current ratio of 0.81. Oracle Co. has a 1 year low of $106.51 and a 1 year high of $198.31.
Oracle (NYSE:ORCL - Get Free Report) last released its earnings results on Monday, December 9th. The enterprise software provider reported $1.47 EPS for the quarter, missing analysts' consensus estimates of $1.48 by ($0.01). Oracle had a return on equity of 133.25% and a net margin of 21.16%. The company had revenue of $14.06 billion for the quarter, compared to analysts' expectations of $14.12 billion. During the same period in the prior year, the firm earned $1.34 EPS. The firm's revenue for the quarter was up 8.6% on a year-over-year basis. Equities research analysts forecast that Oracle Co. will post 5.01 earnings per share for the current fiscal year.
Oracle Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, January 9th. Investors of record on Thursday, January 23rd were paid a dividend of $0.40 per share. The ex-dividend date was Friday, January 10th. This represents a $1.60 annualized dividend and a yield of 0.86%. Oracle's dividend payout ratio is presently 39.12%.
About Oracle
(
Free Report)
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Read More
Before you consider Oracle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.
While Oracle currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.